EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitochondrial Health Through Nicotinamide Riboside and Berberine: Shared Pathways and Therapeutic Potential

Federico Visalli iD, Matteo Capobianco iD, Francesco Cappellani iD, Lorenzo Rapisarda, Alfonso Spinello, Alessandro Avitabile iD, Ludovica Cannizzaro iD, Caterina Gagliano iD, Marco Zeppieri iD

International Journal of Molecular Sciences · 02.01.2026 · 27 (1) · 485

DOI: 10.3390/ijms27010485 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.01.2026. Verfasst von Federico Visalli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Catania, 95123 Catania, Italy. Hauptthemen laut MEDLINE: Niacinamide, Mitochondria, Berberine. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial dysfunction represents a central hallmark of aging and a broad spectrum of chronic diseases, ranging from metabolic to neurodegenerative and ocular disorders. Nicotinamide riboside (NR), a vitamin B3 derivative and efficient precursor of NAD+ (nicotinamide adenine dinucleotide), and berberine (BBR), an isoquinoline alkaloid widely investigated in metabolic regulation, have independently emerged as promising mitochondrial modulators. NR enhances cellular NAD+ pools, thereby activating sirtuin-dependent pathways, stimulating PGC-1α–mediated mitochondrial biogenesis, and triggering the mitochondrial unfolded protein response (UPRmt). BBR, by contrast, primarily activates AMPK (AMP-activated protein kinase) and interacts with respiratory complex I, improving bioenergetics, reducing mitochondrial reactive oxygen species, and promoting mitophagy and organelle quality control. Importantly, despite distinct upstream mechanisms, NR and BBR converge on shared signaling pathways that support mitochondrial health, including redox balance, metabolic flexibility, and immunometabolic regulation. Unlike previous reviews addressing these compounds separately, this article integrates current preclinical and clinical findings to provide a unified perspective on their converging actions. We critically discuss translational opportunities as well as limitations, including heterogeneous clinical outcomes and the need for robust biomarkers of mitochondrial function. By outlining overlapping and complementary mechanisms, we highlight NR and BBR as rational combinatorial strategies to restore mitochondrial resilience. This integrative perspective may guide the design of next-generation clinical trials and advance precision approaches in mitochondrial medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NiacinamideMitochondriaBerberineHumansAnimalsSignal TransductionPyridinium Compounds

Stichwörter der Autor:innen

NAD+ metabolismberberinecardiometabolic diseasemitochondrial dysfunctionneuroprotectionnicotinamidenicotinamide ribosideoxidative stressretinal ganglion cells

Substanzen

NiacinamideBerberinenicotinamide-beta-ribosidePyridinium Compounds

Autor:innen und Institutionen

  • Department of Ophthalmology, University of Catania, 95123 Catania, Italy.
  • Department of Medicine and Surgery, University of Enna "Kore", 94100 Enna, Italy.
  • Mediterranean Foundation "G.B. Morgagni", 95125 Catania, Italy.
  • Azienda Sanitaria Provinciale 8 Siracusa, Presidio Ospedaliero Umberto I, 96100 Siracusa, Italy.
  • Faculty of Medicine, University of Catania, 95123 Catania, Italy.
  • Department of Ophthalmology, University Hospital of Udine, 33100 Udine, Italy.

ORCID-Profile: Federico Visalli, Matteo Capobianco, Francesco Cappellani, Alessandro Avitabile, Ludovica Cannizzaro, Caterina Gagliano, Marco Zeppieri

Zitieren

APA

Visalli, F., Capobianco, M., Cappellani, F., Rapisarda, L., Spinello, A., Avitabile, A., Cannizzaro, L., Gagliano, C., & Zeppieri, M. (2026). Mitochondrial Health Through Nicotinamide Riboside and Berberine: Shared Pathways and Therapeutic Potential. International Journal of Molecular Sciences, 27(1), 485. https://doi.org/10.3390/ijms27010485

Vancouver

Visalli F, Capobianco M, Cappellani F, Rapisarda L, Spinello A, Avitabile A, et al. Mitochondrial Health Through Nicotinamide Riboside and Berberine: Shared Pathways and Therapeutic Potential. International Journal of Molecular Sciences. 2026;27(1):485. doi:10.3390/ijms27010485

BibTeX
@article{Visalli2026,
  author = {Visalli, Federico and Capobianco, Matteo and Cappellani, Francesco and Rapisarda, Lorenzo and Spinello, Alfonso and Avitabile, Alessandro and Cannizzaro, Ludovica and Gagliano, Caterina and Zeppieri, Marco},
  title = {Mitochondrial Health Through Nicotinamide Riboside and Berberine: Shared Pathways and Therapeutic Potential},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {1},
  pages = {485},
  doi = {10.3390/ijms27010485}
}
Kostenlos starten →